The Korean Veterinary Association held 2^nd National Veterinary Advisory Council (NVAC) at Bionote, Inc., on April 26th, 2022.

The NVAC is an official advisory body within the Veterinary Society, providing advice to the government on the prevention of malignant livestock diseases such as FMD, ASF and major zoonotic diseases, while also serving to establish an official veterinary medical system. 

Key figures at NVAC 2022 includes: Chairman Yong-Ho Park (Seoul National University Veterinary College), ▲ Jong-Gu Kang (Biotoxtech), ▲ Jong-Kil Kang (Chunghyeon General Veterinary Hospital), ▲ Gon-Seop Kim (Gyeongsang National University Veterinary College), ▲ Woo-Joo Kim (Korea University Guro Hospital), ▲ Young-Soo Ryu (Konkuk University Veterinary College) , ▲Seungwon Seo (Boehringer Ingelheim Veterinary Medicine), ▲Sangcheol Shin (Solgent), ▲Chunggeun Yoon (Asia Veterinary Hospital), ▲Soodu Lee (Ministry of Food and Drug Safety), ▲Poongkyu Lee (Knowhere bio), ▲Youngsik Cho (Bionote).

For this year's council meeting, Professor Kim Woo-Joo, Department of Infectious Diseases at the Korea University Guro Hospital, discussed the current status of the COVID-19 pandemic, development of vaccines, changes due to the emergence of mutants, and future prospects and countermeasures, under the theme of 'COVID-19 Pandemic: Current Status and Prospects'.

Bionote is the No. 1 manufacturer for veterinary diagnostic reagents in Korea. For its post pandemic growth engine,  Bionote will be focusing on expanding its business sector via molecular diagnostic analyzer Vcheck M, biochemistry analyzer Vcheck C, and bio-contents business.